· Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetration
· New distribution channels to improve access to Atelerix’s non-cryogenic cell preservation solutions and strengthen local technical support
Newcastle, UK, 23 September 2025: Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered into a new distribution agreement with CliniSciences, a leading European player in the distribution and development of solutions for research and diagnostics. Expanding on Atelerix’s global operational scale-up1,2, the large territory, non-exclusive distribution agreement marks the Company’s continued success in addressing the growing demand for its suite of non-cryogenic cell preservation solutions, as well as enabling penetration into the rapidly growing North African life sciences market.
CliniSciences is a recognised distributor for the life science research and diagnostics sector, specialising in reagents and instruments for immunology, cell biology and molecular biology. The team has extensive experience connecting manufacturers of quality research and in vitro diagnostic products with researchers across Europe and are deeply embedded in biopharma and academic purchasing systems. Through the agreement, Atelerix will strengthen its distribution and technical support channels across Europe and establish a presence in North Africa, significantly bolstering its customer base via CliniSciences’ reputable network.
Atelerix is pursuing an ambitious commercial strategy to proactively address market requirements for high-quality, temperature-sensitive products. The Company’s patented hydrogel-based solutions for preserving cell and tissue viability address critical challenges in the transport of temperature-sensitive biological samples without the need for cryopreservation, which is associated with complicated shipping and handling protocols, high waste and energy consumption, and loss of cell viability.
“Europe is one of the world’s largest markets in life science research,” commented Wilfried Gay, Scientific Manager, CliniSciences. “Atelerix’s patented hydrogels offer a unique approach to cell preservation and the transport of other temperature-sensitive biological substances to address obstacles in the logistics supply chain. We’re pleased to enter into this new partnership with Atelerix, which will allow us to bring these innovative cell preservation solutions to our customers, and let them focus on what is most important to them – advancing ground-breaking research.”
Alastair Carrington, CEO, Atelerix, added: “With its established customer base and extensive team of technical experts across the continent, CliniSciences was the obvious choice of partner to expand our operations in Europe and enter the burgeoning North African life science market. Together, we are not only strengthening our presence in these key regions but also removing barriers to adoption – making it simpler for companies worldwide to access our products and integrate them into their own supply chain. Myself and the team look forward to working with CliniSciences to maximise value for customers, ensure our mutual success, and enable effective support for global markets.”
1. Press Release (16th April 2025): Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China
2. Press Release (3rd September 2025): Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions
ENDS
Notes to Editors:
|
|
|
|
Alastair Carrington, CEO, Atelerix |
|
For high-resolution images, please contact Zyme Communications.
For further information, please contact:
Alastair Carrington
Atelerix
Email: alastair.carrington@atelerix.co.uk
Zyme Communications
Zyme Communications
Tel: +44(0) 7759 162 147
Email: jake.brown@zymecommunications.com
To opt out from receiving press releases from Zyme Communications please email info@zymecommunications.com. To view our privacy policy please click here.
About Atelerix www.atelerix.co.uk
Atelerix is pioneering a unique approach to non-cryogenic storage and transport of biological samples with its hypothermic preservation technology.
Derived from seaweed and inspired by the hibernation of the African four-toed pygmy hedgehog, Atelerix’s hydrogel-based solutions alleviate the need for costly and energy-intensive cold chain supply. The hydrogels are designed to physically encapsulate cells and stabilise lipid membrane integrity, enabling the stable storage of cells, tissues and viruses at room temperature for up to two weeks.
To find out more, please visit www.atelerix.co.uk, and follow us on LinkedIn.
